For research use only. Not for therapeutic Use.
Remlarsen (MRG-201), a miR-29b mimic, acts a miR-29b agonist. Remlarsen has the potential for preventiong formation of a fibrotic scar or cutaneous fibrosis[1].
Remlarsen (MRG-201) is active in regulating PD biomarker expression in the skin[1].
Catalog Number | I045365 |
CAS Number | 1848266-71-6 |
Purity | ≥95% |
Reference | [1]. Corrie L Gallant-Behm, et al. A MicroRNA-29 Mimic (Remlarsen) Represses Extracellular Matrix Expression and Fibroplasia in the Skin. J Invest Dermatol. 2019 May;139(5):1073-1081. |